RS51119B - Formulacije benzotijazola i njegova upotreba - Google Patents

Formulacije benzotijazola i njegova upotreba

Info

Publication number
RS51119B
RS51119B RSP-2009/0024A RSP20090024A RS51119B RS 51119 B RS51119 B RS 51119B RS P20090024 A RSP20090024 A RS P20090024A RS 51119 B RS51119 B RS 51119B
Authority
RS
Serbia
Prior art keywords
alkoxy
well
benzothiazole
amino
group
Prior art date
Application number
RSP-2009/0024A
Other languages
English (en)
Serbian (sr)
Inventor
Pascale Gaillard
Pierandrea Esposito
Daniela Chicco
Luca Donati
Andrea Leonardi
Stefania Bertero
Jean-Pierre Gotteland
Isabelle Jeanclaude-Etter
Simone Grandolini
Mario Maio
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Priority claimed from PCT/EP2005/056020 external-priority patent/WO2006053882A2/en
Publication of RS51119B publication Critical patent/RS51119B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RSP-2009/0024A 2004-11-17 2005-11-16 Formulacije benzotijazola i njegova upotreba RS51119B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04105843 2004-11-17
US62899804P 2004-11-18 2004-11-18
PCT/EP2005/056020 WO2006053882A2 (en) 2004-11-17 2005-11-16 Benzothiazole formulations and use thereof

Publications (1)

Publication Number Publication Date
RS51119B true RS51119B (sr) 2010-10-31

Family

ID=34929876

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0024A RS51119B (sr) 2004-11-17 2005-11-16 Formulacije benzotijazola i njegova upotreba

Country Status (4)

Country Link
CN (1) CN101102796A (zh)
RS (1) RS51119B (zh)
UA (1) UA87524C2 (zh)
ZA (1) ZA200703998B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014114186A1 (zh) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Jnk抑制剂
JP2022523106A (ja) * 2019-01-31 2022-04-21 スピノジェニックス， インコーポレイテッド スパイン形成の促進因子の固体形態

Also Published As

Publication number Publication date
ZA200703998B (en) 2008-11-26
UA87524C2 (ru) 2009-07-27
CN101102796A (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
HRP20070499A2 (en) Spiroheterocyclic compounds and their uses as therapeutic agents
HRP20070505B1 (hr) Spiro-oksindol spojevi i njihove upotrebe kao terapijska sredstva
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
RS52245B (en) CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THErapeutic Use
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
DE60336014D1 (de) Pyrrolobenzodiazepine zur behandlung proliferativer erkrankungen
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PE20090423A1 (es) Compuestos moduladores de sirtuina
NO20091892L (no) Krystallinsk form av (3S)-3-(N-(N`-(2-tert-butylfenyl)oksamyl) alaninyl)amino-5-(2`,3`,5`,6`-tetrafluorfenoksy)-4 oksopentanoisk syre
EA200801011A1 (ru) Производные пиразина как модуляторы натриевых каналов для лечения боли
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
HRP20080544T3 (en) Benzothiazole formulations and use thereof
EA200802173A1 (ru) Производные терфенила для лечения болезни альцгеймера
EA201070018A1 (ru) Замещенные 2-[2-(фенил)этиламино] алканамидные производные и применение указанных соединений в качестве модуляторов натриевых и/или кальциевых каналов
IN266803B (zh)
SE0301446D0 (sv) New Compounds
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
HRP20041030B1 (hr) Derivati benzoksazina kao regulatori 5-ht6 i njihova upotreba
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
WO2007020411A8 (en) Amide derivatives
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении